Cape Ann Savings Bank Abbott Laboratories Transaction History

Cape Ann Savings Bank

$166 Million
Q4 2024

A detailed history of Cape Ann Savings Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Cape Ann Savings Bank holds 2,293 shares of ABT stock, worth $295,957. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,293

Previous 2,453 6.52%

Holding current value

$295,957

Previous $279,000 7.17%

% of portfolio

0.16%

Previous 0.16%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$111.93 - $119.39 $17,908 - $19,102	-160 Reduced 6.52%	2,293 $259,000
Q3 2024 Oct 08, 2024	BUY	$100.07 - $118.13 $16,511 - $19,491	165 Added 7.21%	2,453 $279,000
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $6,043 - $6,746	-60 Reduced 2.56%	2,288 $237,000
Q4 2023 Mar 15, 2024	SELL	$90.19 - $110.4 $6,764 - $8,280	-75 Reduced 3.1%	2,348 $258,000
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $17,673 - $21,204	-185 Reduced 7.09%	2,423 $234,000
Q2 2023 Sep 18, 2023	BUY	$100.78 - $112.29 $262,834 - $292,852	2,608 New	2,608 $284,000
Q1 2023 Sep 18, 2023	SELL	$96.86 - $114.01 $259,972 - $306,002	-2,684 Closed	0 $0
Q2 2022 Aug 24, 2022	SELL	$102.07 - $123.37 $15,310 - $18,505	-150 Reduced 5.29%	2,684 $292,000
Q1 2022 May 18, 2022	SELL	$114.02 - $139.04 $376,722 - $459,388	-3,304 Reduced 53.83%	2,834 $335,000
Q4 2021 Feb 16, 2022	SELL	$115.53 - $141.46 $36,045 - $44,135	-312 Reduced 4.84%	6,138 $864,000
Q3 2021 Nov 22, 2021	SELL	$116.66 - $129.06 $17,615 - $19,488	-151 Reduced 2.29%	6,450 $762,000
Q2 2021 Aug 17, 2021	SELL	$105.79 - $124.53 $9,732 - $11,456	-92 Reduced 1.37%	6,601 $765,000
Q1 2021 May 25, 2021	SELL	$108.84 - $128.23 $37,223 - $43,854	-342 Reduced 4.86%	6,693 $802,000
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $159,075 - $173,346	-1,515 Reduced 17.72%	7,035 $770,000
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $30,704 - $39,298	-401 Reduced 4.48%	8,550 $782,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $20,460 - $22,185	-250 Reduced 2.72%	8,951 $749,000
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $54,660 - $63,750	-750 Reduced 7.54%	9,201 $773,000
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $52,446 - $63,407	-792 Reduced 7.37%	9,951 $795,000
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $47,727 - $54,068	-728 Reduced 6.35%	10,743 $777,000
Q3 2018 Oct 23, 2018	SELL	$60.81 - $73.36 $1,277 - $1,540	-21 Reduced 0.18%	11,471 $842,000
Q3 2018 Oct 22, 2018	BUY	$60.81 - $73.36 $698,828 - $843,053	11,492 New	11,492 $733,000

Others Institutions Holding ABT

# of Institutions

3,247

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cape Ann Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cape Ann Savings Bank with notifications on news.

Account

Cape Ann Savings Bank Abbott Laboratories Transaction History